retatrutide phase 2 type 2 diabetes weight loss 2024 trial Retatrutide, an experimental weight-loss drug Lilly's triple agonist, retatrutide, Phase III retatrutide study demonstrates
Pay in 4 interest-free payments of $6.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25

























